Magnetic Core For Medical Procedures - Patent 7560058

BACKGROUNDA number of medical ailments are treated or treatable and/or diagnosed through the application of a magnetic field to an afflicted portion of a patient's body. Neurons and muscle cells are a form of biological circuitry that carry electricalsignals and respond to electromagnetic stimuli. When an ordinary conductive wire loop is passed through a magnetic field or is in the presence of a changing magnetic field, an electric current is induced in the wire.The same principle holds true for conductive biological tissue. When a changing magnetic field is applied to a portion of the body, neurons may be depolarized and stimulated. Muscles associated with the stimulated neurons can contract as thoughthe neurons were firing by normal causes.A nerve cell or neuron can be stimulated in a number of ways, including transcutaneously via transcranial magnetic stimulation (TMS), for example. TMS uses a rapidly changing magnetic field to induce a current on a nerve cell, without having tocut or penetrate the skin. The nerve is said to "fire" when a membrane potential within the nerve rises with respect to its normal negative ambient level of approximately -90 millivolts, depending on the type of nerve and local pH of the surroundingtissue.The use of magnetic stimulation is very effective in rehabilitating injured or paralyzed muscle groups. Apart from stimulation of large muscle groups such as the thigh or the abdomen, experimentation has been performed in cardiac stimulation aswell. In this context, magnetic stimulation of the heart may prove to be superior to CPR or electrical stimulation, because both of those methods undesirably apply gross stimulation to the entire heart all at once.Another area in which magnetic stimulation is proving effective is treatment of the spine. The spinal cord is difficult to access directly because vertebrae surround it. Magnetic stimulation may be used to block the transmission of pain vianerves in the back, e.g., those responsi

United States Patent: 7560058
&nbsp;
( 1 of 1 )
United States Patent
7,560,058
Riehl
, &nbsp; et al.
July 14, 2009
Magnetic core for medical procedures
Abstract
The inventive technique include a system, method and device for treating a
patient. The device includes a magnetic device having a core created by a
binder process having a relatively low temperature. The device further
includes a conductor in electrical communication with the core.
Inventors:
Riehl; Mark Edward (Doylestown, PA), Ghiron; Kenneth Marc (Allentown, PA)
Assignee:
Neuronetics, Inc.
(Malvern,
PA)
Appl. No.:
11/325,660
Filed:
January 4, 2006
Related U.S. Patent Documents
Application NumberFiling DatePatent NumberIssue Date
11213415Aug., 2005
11191106Jul., 2005
Current U.S. Class:
264/115 ; 264/109; 264/122
Current International Class:
B29C 43/02&nbsp(20060101)
References Cited [Referenced By]
U.S. Patent Documents
3197678
July 1965
Jaroslav
3658051
April 1972
Maclean
3683923
August 1972
Anderson
4473074
September 1984
Vassiliadis
4601753
July 1986
Soileau et al.
4638798
January 1987
Shelden et al.
4712558
December 1987
Kidd et al.
4994015
February 1991
Cadwell
4995395
February 1991
Ilmoniemi et al.
5063011
November 1991
Rutz et al.
5078674
January 1992
Cadwell
5097833
March 1992
Campos
5116304
May 1992
Cadwell
5154723
October 1992
Kubota et al.
5160447
November 1992
Ishikawa et al.
5178757
January 1993
Corney
5211896
May 1993
Ward et al.
5254123
October 1993
Bushey
5268140
December 1993
Rutz et al.
5299569
April 1994
Wernicke et al.
5543174
August 1996
Rutz
5566681
October 1996
Manwaring et al.
5591373
January 1997
Ward et al.
5707334
January 1998
Young
5725471
March 1998
Davey et al.
5769778
June 1998
Abrams et al.
5812301
September 1998
Nakamura et al.
5813970
September 1998
Abrams et al.
5820623
October 1998
Ng
5898253
April 1999
El-Antably et al.
6002251
December 1999
Sun
6057373
May 2000
Fogel
6066084
May 2000
Edrich et al.
6074385
June 2000
Klopotek
6086525
July 2000
Davey et al.
6117066
September 2000
Abrams et al.
6132361
October 2000
Epstein et al.
6155966
December 2000
Parker
6169963
January 2001
Markov
6179769
January 2001
Ishikawa et al.
6179771
January 2001
Mueller
6198958
March 2001
Ives et al.
6205356
March 2001
Holcomb
6210317
April 2001
Bonlie
6253109
June 2001
Gielen
6256531
July 2001
Ilmoniemi et al.
6266556
July 2001
Ives et al.
6279579
August 2001
Riaziat et al.
6355049
March 2002
Gill
6366814
April 2002
Boveja et al.
6389318
May 2002
Zarinetchi et al.
6402678
June 2002
Fischell et al.
6413263
July 2002
Lobdill et al.
6425852
July 2002
Epstein et al.
6463328
October 2002
John
6477410
November 2002
Henley et al.
6480743
November 2002
Kirkpatrick et al.
6484059
November 2002
Gielen
6488617
December 2002
Katz
6497648
December 2002
Rey
6500110
December 2002
Davey et al.
6503187
January 2003
Ilmoniemi et al.
6516288
February 2003
Bagne
6537197
March 2003
Ruohonen et al.
6560490
May 2003
Grill et al.
6567702
May 2003
Nekhendzy et al.
6571123
May 2003
Ives et al.
6572528
June 2003
Rohan et al.
6618614
September 2003
Chance
6629935
October 2003
Miller et al.
6641520
November 2003
Bailey et al.
6663556
December 2003
Barker
6827681
December 2004
Tanner et al.
6849040
February 2005
Ruohonen et al.
6954060
October 2005
Edel
6978179
December 2005
Flagg et al.
7367936
May 2008
Myers et al.
7407478
August 2008
Zangen et al.
2001/0012912
August 2001
Feucht
2001/0016977
August 2001
Moro et al.
2001/0018547
August 2001
Mechlenburg et al.
2001/0031906
October 2001
Ishikawa et al.
2002/0013612
January 2002
Whitehurst
2002/0087201
July 2002
Firlik et al.
2002/0091419
July 2002
Firlik et al.
2002/0103515
August 2002
Davey et al.
2002/0123780
September 2002
Grill et al.
2002/0160436
October 2002
Markov et al.
2002/0169355
November 2002
Rohan et al.
2003/0004392
January 2003
Tanner et al.
2003/0023159
January 2003
Tanner
2003/0028072
February 2003
Fischell et al.
2003/0050527
March 2003
Fox et al.
2003/0073899
April 2003
Ruohonen et al.
2003/0074032
April 2003
Gliner et al.
2003/0082507
May 2003
Stypulkowski
2003/0087264
May 2003
Kaplitt et al.
2003/0088274
May 2003
Gliner et al.
2003/0097161
May 2003
Firlik et al.
2003/0125786
July 2003
Gliner et al.
2003/0130706
July 2003
Sheffield et al.
2003/0195588
October 2003
Fischell et al.
2003/0204135
October 2003
Bystritsky
2004/0010177
January 2004
Rohan et al.
2004/0051279
March 2004
Grant et al.
2004/0077921
April 2004
Becker et al.
2004/0077923
April 2004
Frimerman et al.
2004/0122281
June 2004
Fischell et al.
2004/0127942
July 2004
Yomtov et al.
2004/0138524
July 2004
Ueda et al.
2004/0138550
July 2004
Hartlep et al.
2004/0143300
July 2004
Rogers
2004/0153129
August 2004
Pless et al.
2004/0172012
September 2004
Otsuka et al.
2004/0193001
September 2004
Miller
2004/0204625
October 2004
Riehl et al.
2005/0021104
January 2005
DiLorenzo
2005/0124848
June 2005
Holzner
2005/0212162
September 2005
Aisenbrey
2005/0216071
September 2005
Devlin et al.
2005/0228209
October 2005
Schneider et al.
2005/0256539
November 2005
George et al.
2006/0113696
June 2006
Aisenbrey
2006/0199992
September 2006
Eisenberg et al.
Foreign Patent Documents
1 273 320
Jan., 2003
EP
WO 99/64884
Dec., 1999
WO
WO 00/74777
Dec., 2000
WO
WO 01/12236
Feb., 2001
WO
WO 01/28622
Apr., 2001
WO
WO 01/97906
Dec., 2001
WO
WO 02/09811
Feb., 2002
WO
WO 02/31604
Apr., 2002
WO
WO 02/032504
Apr., 2002
WO
WO 02/072194
Sep., 2002
WO
WO 02/085449
Oct., 2002
WO
WO 02/085454
Oct., 2002
WO
WO 02/089902
Nov., 2002
WO
WO 02/094997
Nov., 2002
WO
WO 03/035163
May., 2003
WO
WO 03/039468
May., 2003
WO
WO 03/082405
Oct., 2003
WO
WO 03/084605
Oct., 2003
WO
WO 03/085546
Oct., 2003
WO
WO 03/090604
Nov., 2003
WO
WO 03/098268
Nov., 2003
WO
WO 2004/006750
Jan., 2004
WO
WO 2004/082759
Sep., 2004
WO
WO 2004/100765
Nov., 2004
WO
WO 2005/000401
Jan., 2005
WO
WO 2005/065768
Jul., 2005
WO
Other References
Awiszus, F. et al., "Characterization of Paired-Pulse Transcranial Magnetic Stimulation Conditions Yielding Intracortical Inhibition of I-Wave
Facilitation using a Threshold Paradigm", Experimental Brain Research, 1999, 129, 317-324. cited by other
.
Keiji, I. et al., "Effects of Transcranial Magnetic Stimulation on EEG Activity", IEEE transactions on Magnetics, 2002, 38(5), 3347-3349, XP 011075410. cited by other
.
Pascual-Leone, A. et al., "Rapid-Rate Transcranial Magnetic Stimulation of Left Dorsolateral Prefrontal Cortex in Drug-Resistant Depression", The Lancet, 1996, 18, 233-237. cited by other
.
Sommer, M. et al., "Increased Transcranial Magnetic Motor Threshold after ECT", European Archives of Psychiatry and Clinical Neuroscience, 2002, 252, 250-252. cited by other
.
Baudewig, J. et al., "Functional MRI of Cortical Activations Induced by Transcranial Magnetic Stimulation(TMS)", Brain Imaging-NeuroReport, 2001, 12(16), 3543-3548. cited by other
.
Bohning, D.E. et al., "A TMS Coil Positioning/Holding System for MR Image-Guided TMS Interleaved with fMRI", Clinical Neurophysiology, 2003, 114, 2210-2219. cited by other
.
Bohning, D.E. Ph.D. et al., "A Combined TMS/fMRI Study of Intensity-Dependant TMS over Motor Cortex", Society of Biological Psychiatry, 1999, 45, 385-394. cited by other
.
Bohning, D.E. Ph.D. et al., "BOLD-fMRI Response to Single-Pulse Transcranial Magnetic Stimulation (TMS)", Journal of Magnetic Resonance Imaging, 2000, 11, 569-574. cited by other
.
Garcia-Toro, M. et al., "Modest Adjunctive Benefit with Transcranial Magnetic Stimulation in Medication-Resistant Depression", Journal of Affective Disorders, 2001, 64, 271-275. cited by other
.
George, M.S. et al., "A Controlled Trial of Daily Left Prefrontal Cortex TMS for Treating Depression", Society of Biological Psychiatry, 2000, 48, 962-970. cited by other
.
George, M.S. "New Methods of Minimally Invasive Brain Modulation as Therapies in Psychiatry: TMS,MST,VNS and DBS", Chinese Medical Journal (Taipei), 2002, 65, 349-360. cited by other
.
Grafman, J. Ph. D., "TMS as a Primary Brain Mapping Tool" Transcranial Magnetic Stimulation in Neuropsychiatry, 2000, 115-140. cited by other
.
Nahas, Z.et al., "Left Prefrontal Transcranial Magnetic Stimulation(TMS) Treatment of Depression in Bipolar Affective Disorder: A Pilot Study of Acute Safety and Efficacy", Bipolar Disorders, 2003, 5, 40-47. cited by other
.
Lisanby, S.H. MD. et al., "Magnetic Seizure therapy of Major Depression", Arch Gen Psychiatry, 2001, 58, 303-307. cited by other
.
Lisanby, S.H. et al., "Sham TMS: Intracerebral Measurement of the Induced Electrical Field and the Induction of Motor-Evoked Potentials", Society of Biological Psychiatry, 2001, 49, 460-463. cited by other
.
Lisanby, S.H., "Safety and Feasibility of Magnetic Seizure Therapy(MST) in Major Depression: Randomized Within-Subject Comparasion with Electroconvulsive Therapy", Neuropsychopharmacology, New York State Psychiatric Institute, 2003, 28, 1852-1865.
cited by other
.
Lisanby, S.H., "Update on Magnetic Seizure Therapy: A Novel Form of Convulsive Therapy", The Journal of ECT, 2002, 18, 182-188. cited by other
.
Lorberbaum, J.P., M.D. et al., "Safety Concerns of TMS", Transcranial Magnetic Stimulation in Neuropsychiatry, 2000, 141-161. cited by other
.
Loo, C.K. et al., "Transcranial Magnetic Stimulation (TMS) in Controlled Treatment Studies: Are Some "Sham" Forms Active?", Society of Biological Psychiatry, 2000, 47, 325-331. cited by other
.
Nahas, Z. et al., "Unilateral Left Prefrontal Transcranial Magnetic Stimulation(TMS) Produces Intensity-Dependent Bilateral Effects as Measured by Interleaved BOLD fMRI", Society of Biological Psychiatry, 2001, 50, 712-720. cited by other
.
Pridmore, S., "Rapid Transcranial Magnetic Stimulation and Normalization of the Dexamethasone Suppression Test", Psychiatry and Clinical Neurosciences, 1999, 53, 33-37. cited by other
.
Roth, Y. et al., "A Coil Design for Transcranial Magnetic Stimulation of Deep Brain Regions", Journal of Clinical Neurophysiology, 2002, 19(4), 361-370. cited by other
.
Ruohonen, J., "Electroencephalography Combined with TMS", BioMag Laboratory, Helsinki University Central Hospital, http://www.biomag.helsinki.fi/tms/TMSEEG.html, Oct. 6, 1999, 22 pages. cited by other
.
Terrace, H.S. et al., "The Cognitive Effects of Electroconvulsive Shock and Magnetic Seizure Therapy in Rhesus Monkeys", Society for Neuroscience Abstract Viewer and Itinerary Planner, 2002, Abstract Only #184.14. cited by other
.
Terrace, H.S. et al., "The Cognitive Effects of Electroconvulsive Shock Stimulation and Magnetic Seizure Therapy in Rhesus Monkeys", Society for Neuroscience Abstracts, 2001, 27(1), 536.7, p. 1418. cited by other
.
Trivedi, M.H. MD., "Treatment-Resistant Depression: New Therapies on the Horizon", Annals of Clinical Psychiatry, 2003, 15(1), 59-70. cited by other
.
Hess, C.W. et al., "Magnetic Stimulation of the Human Brain: Influence of Size and Shape of the Stimulating Coil", Motor Disturbances II, 1990, 3, 31-42. cited by other
.
Wassermann, E.M., "Repetitive Transcranial Magnetic Stimulation: An Intoduction and Overview", CNS Spectrums, The International Journal of Neuropsychiatric Medicine, Jan. 1997, 7 pages. cited by other
.
In the United States Patent and Trademark Office, Non-Final Office Action In re:. U.S. Appl. No. 11/213,415 filed Aug. 26, 2005, dated Nov. 15, 2006, 28 pages. cited by other
.
In the United States Patent and Trademark Office, Final Office Action In re:. U.S. Appl. No. 11/213,415 filed Aug. 26, 2005, dated Aug. 9, 2007, 15 pages. cited by other
.
In the United States Patent and Trademark Office,Non-Final Office Action In re:. U.S. Appl. No. 11/213,415 filed Aug. 26, 2005, dated Feb. 8, 2008, 14 pages. cited by other
.
In the United States Patent and Trademark Office,Non-Final Office Action In re:. U.S. Appl. No. 11/191,106 filed Jul. 27, 2005, dated Aug. 12, 2008, 22 pages. cited by other.
Primary Examiner: Theisen; Mary Lynn F
Attorney, Agent or Firm: Woodcock Washburn LLP
Parent Case Text
CROSS-REFERENCE TO RELATED APPLICATIONS
This application is a continuation of U.S. patent application Ser. No.
11/191,106, filed Jul. 27, 2005 entitled "Magnetic Core for Medical
Treatment," which is herein incorporated by reference in its entirety.
Also, this application is a continuation of U.S. patent application Ser.
No. 11/213,415, filed Aug. 26, 2005 entitled "Magnetic Core for Medical
Treatment," which is herein incorporated by reference in its entirety.
Claims
What is claimed is:
1. A method of manufacturing a magnetic core for treating a patient, comprising: selecting one or more ferromagnetic materials; mixing the ferromagnetic materials with a
non-conductive material; forming the ferromagnetic materials into a non-linear core structure, wherein the non-linear core structure is formed for placement of at least one pole face in proximity to the patient for applying a magnetic field to a target
anatomy; and compressing the ferromagnetic material using a binder process.
2. The method of claim 1, wherein the binder process comprises at least one of the following: thermally set having a relatively low temperature, pressure or chemical.
3. The method of claim 1, wherein the binder process comprises at least one of the following: thermally set, pressure or chemical.
4. The method of claim 1, wherein the core is created using a ferromagnetic powder material.
5. The method of claim 1, further comprising placing a conductor in communication with the core structure.
6. The method of claim 5, wherein the conductor comprises multiple strands in parallel electrically.
7. The method of claim 5, wherein the conductor comprises a metal sheet of conductive material.
8. The method of claim 5, wherein the conductor comprises an extruded magnet wire.
9. The method of claim 1, wherein the non-linear core structure has a non-toroidal geometry.
10. The method of claim 3, wherein the thermally set binder process is a non-sintered process.
11. The method of claim 1, wherein the magnetic core saturates at 0.5 Tesla or greater. Description
BACKGROUND
A number of medical ailments are treated or treatable and/or diagnosed through the application of a magnetic field to an afflicted portion of a patient's body. Neurons and muscle cells are a form of biological circuitry that carry electrical
signals and respond to electromagnetic stimuli. When an ordinary conductive wire loop is passed through a magnetic field or is in the presence of a changing magnetic field, an electric current is induced in the wire.
The same principle holds true for conductive biological tissue. When a changing magnetic field is applied to a portion of the body, neurons may be depolarized and stimulated. Muscles associated with the stimulated neurons can contract as though
the neurons were firing by normal causes.
A nerve cell or neuron can be stimulated in a number of ways, including transcutaneously via transcranial magnetic stimulation (TMS), for example. TMS uses a rapidly changing magnetic field to induce a current on a nerve cell, without having to
cut or penetrate the skin. The nerve is said to "fire" when a membrane potential within the nerve rises with respect to its normal negative ambient level of approximately -90 millivolts, depending on the type of nerve and local pH of the surrounding
tissue.
The use of magnetic stimulation is very effective in rehabilitating injured or paralyzed muscle groups. Apart from stimulation of large muscle groups such as the thigh or the abdomen, experimentation has been performed in cardiac stimulation as
well. In this context, magnetic stimulation of the heart may prove to be superior to CPR or electrical stimulation, because both of those methods undesirably apply gross stimulation to the entire heart all at once.
Another area in which magnetic stimulation is proving effective is treatment of the spine. The spinal cord is difficult to access directly because vertebrae surround it. Magnetic stimulation may be used to block the transmission of pain via
nerves in the back, e.g., those responsible for lower back pain.
Magnetic stimulation also has proven effective in stimulating regions of the brain, which is composed predominantly of neurological tissue. One area of particular interest is the treatment of depression. It is believed that more than 28 million
people in the United States alone suffer from some type of neuropsychiatric disorder. These include conditions such as depression, schizophrenia, mania, obsessive-compulsive disorder, panic disorders, and others. Depression is the "common cold" of
psychiatric disorders, believed to affect 19 million people in the United States and possibly 340 million people worldwide.
Modern medicine offers depression patients a number of treatment options, including several classes of anti-depressant medications (e.g., SSRI's, MAOI's and tricyclics), lithium, and electroconvulsive therapy (ECT). Yet many patients remain
without satisfactory relief from the symptoms of depression. To date, ECT remains an effective therapy for resistant depression; however, many patients will not undergo the procedure because of its severe side effects.
Recently, repetitive transcranial magnetic stimulation (rTMS) has been shown to have significant anti-depressant effects for patients that do not respond to the traditional methods. The principle behind rTMS is to apply a subconvulsive
stimulation to the prefrontal cortex in a repetitive manner, causing a depolarization of cortical neuron membranes. The membranes are depolarized by the induction of small electric fields in excess of 1 V/cm that are the result of a rapidly changing
magnetic field applied non-invasively.
Creation of the magnetic field has been varied. Certain techniques describe the use of a coil to create the necessary magnetic field. Other techniques contemplate the use of a high saturation level magnetic core material, like vanadium
permendur. Use of the magnetic core material, as compared to the coil or so-called "air" core solution, has been shown to increase the efficiency of the TMS process. For example, as discussed with reference to U.S. Pat. No. 5,725,471, using a
magnetic core instead of just a coil increases the efficiency of the TMS process by creating a larger, more focused magnetic field with the same or lesser input power requirements.
This advance has allowed a more cost effective solution that uses existing 120 volt power without complicated and a costly power supplies. Also, because of the need for the same or lesser power inputs, the magnetic core significantly reduces the
undesirable heating that was associated with the coil solution and created a safety risk for patients. For example, magnetic core devices in comparison to coil-only devices reduce the magnetic reluctance path by a factor of two. This reluctance
reduction translates into a reduction of required current to generate the same magnetic field by the same factor, and thus provides a fourfold reduction in required power.
The ferromagnetic core alternatives typically are fabricated by laminating layers of silicon steel or similar ferromagnetic metal together to form the core structure. The layers may be constructed by stacking cut-out shapes or by winding a
ribbon of material onto a mandrel followed by further machining and processing to attain the desired core geometry.
While solutions fabricated using these ferromagnetic cores offered a marked improvement over their coil-only counterparts, the ferromagnetic cores also suffer from certain complexities in their construction and limitations in their geometry.
Specifically, the stacked layer construction method does not provide optimal alignment of the metal crystal structure with the magnetic flux lines and also requires a controlled lamination process to guarantee minimal eddy current losses. The wound
ribbon construction method typically results in a core with arc-shaped or C-shaped structure having a certain radius and span. The dimensions and geometry of these ferromagnetic cores are selected to ensure desired depth of penetration, magnetic field
shape and appropriate magnetic field magnitude at certain locations within the patient's anatomy.
The ferromagnetic core's construction method involves a complex and meticulous construction process that increased both the complexity and cost of the core. For example, because ferromagnetic material is electrically conductive, eddy currents
are established in the material when it is exposed to a rapidly varying magnetic field. These eddy currents not only heat the core material through resistive heating, but they also produce an opposing magnetic field that diminishes the primary magnetic
field. To prevent these losses the eddy current pathways are broken by fabricating the core from very thin layers or sheets of ferromagnetic material that are electrically isolated from each other.
The sheets typically are individually varnished or otherwise coated to provide insulation between the sheets, thus preventing current from circulating between sheets and resulting in reduced eddy current losses. Also, the sheets are oriented
parallel to the magnetic field to assure low reluctance.
The wound core fabrication process begins by winding a long thin ribbon of saturable ferromagnetic material, such as vanadium permendur or silicon steel, on a mandrel to create the desired radius, thickness and depth of the core. Each side of
the ribbon typically is coated with a thin insulative coating to electrically isolate it. Once the ribbon has been wound on the mandrel to the desired dimensions, it is removed from the mandrel and dipped in epoxy to fix its position. Once the epoxy
has cured, a sector of the toroidal core is cut with a band saw and removed, thus forming the desired arc-shape. Because the cutting process may reduce the electrical isolation of adjacent laminations, each cut is finely ground so that it is smooth, and
then a deep acid etch is performed. The deep etch is performed by dipping each of the cut ends in an acid bath. This removes any ferromagnetic material that may be shorting the laminations. Following the deep etch, the faces are coated to prevent
oxidation and to maintain the shape and structural integrity of the core. The manufacturing process of cutting, coating, aligning, attaching and laminating the layers makes for a complex and costly manufacturing process. Also, these considerations make
it difficult to change or customize the shape of the core structure.
Winding a coil of insulated wire around the ferromagnetic core to deliver the current needed to create the magnetic field also is a complex and detailed process. A typical inductance for a core of this type is about 15-20 microHenries. Each
pass of the winding around the core must be made at precise intervals on the core structure. In the simplest configuration, each core has only one winding, although typically the core may be wound multiple times.
While the present ferromagnetic core shape and composition work well, and certainly better than the coil-only approach, it should be appreciated that other core compositions and core shapes may work equally well under other circumstances.
SUMMARY
The inventive technique include a system, method and device for treating a patient. The device includes a magnetic device having a core created by a binder process having a relatively low temperature. The device further includes a conductor in
electrical communication with the core.
BRIEF DESCRIPTION OF THE DRAWINGS
FIGS. 1 through 13 illustrate example core shapes and configurations, in accordance with the invention;
FIG. 14 is a flow diagram of a method for treating a patient;
FIG. 15 is a block diagram of a system for treating a patient; and
FIG. 16 is a flow diagram of a method for manufacturing a magnetic core for treating a patient.
DETAILED DESCRIPTION
In one embodiment of the invention, a distributed gap core structure is contemplated, for example an air gap core structure. It should be appreciated that the air gap core refers to the internal structure of a magnetic core, while the "air core"
discussed in the Background of the Invention section refers to a winding without any magnetic core. One type of distributed air gap core structure is created by dispersing powdered ferromagnetic particles in a matrix of insulating material. It should
be appreciated that the invention is not limited to an ferromagnetic powder core, but various embodiments may include any gap core structure. The gap core structure may be any structure where one or more conductive particles are insulated (or nearly so)
from each other.
The use of distributed gap core structures, like powdered ferromagnetic core materials reduces the complex manufacturing and corresponding cost burden inherent in the laminated structures. In addition, because of the insulating material that
separates the ferromagnetic particles in the core material, the core is less conductive, and as a result eddy current losses are minimal. More specifically, the non-conductive gaps may prohibit the flow of current from one ferromagnetic particle to the
next, and thus reduce overall current flow in the core. Because eddy currents result from the conductive flow of current in magnetic materials like the core, reducing the conductive flow serves to reduce the eddy currents. As a result of the reduced
eddy currents, the distributed gap core structure produces even less heat than its counterpart ferromagnetic core structures.
Therefore, higher power and current levels may be used to drive coils fabricated with a distributed gap core without concern for heating that may be excessive for a patient undergoing treatment. Moreover, these higher power levels may be
achieved without the need for sophisticated cooling systems, typical of the "air" core solutions. In addition, these higher current drive levels may drive the distributed gap cores closer to their saturation level to obtain greater magnetic field
strength, without concern for consequent undesirable heating. In fact, in some embodiments, heating due to resistive losses in the windings may be greater than heat generated within the distributed gap core material. In other words, the heating
characteristics of the windings may provide the only real heating concerns for patient use.
Reducing eddy current losses and the concomitant reduction in heat generation permits operation of the magnetic core at proportionally higher duty cycles. From a medical application perspective, relatively greater and more intense therapy may be
achieved, which may be beneficial for certain applications. In addition to its inherent reduced temperature, the core may additionally be enclosed in a structure that further enhances its thermal performance. For example, by potting the core into a
shell heat may be directed to a desirable surface for radiation to the surrounding air. Such a surface may, for example, be located away from surfaces that touch a patient or the operator.
Air spaces and thermal insulation also may be added between the windings or other heat generating materials to insulate them from surfaces that may come in contact with a patient, for example. Typically these surfaces must be kept at or below
41.5 degrees Celsius in order to comply with medical device standards, well known to those skilled in the art.
It also should be appreciated that the reduced current flow and eddy current loss gained with the distributed gap core structure is not found in the cores created by a sintering process. This is due, in part, because the sintering process
operates to place the insulated iron powder particles back into electrical conductivity with one another, and thus promote current flow and increased eddy current losses.
The insulative material may be any material that offers a different level of permeability and inductance as compared to the ferromagnetic particles. By introducing an insulative gap, the magnetic flux path is increased, thus reducing the
permeability and the inductance of the core material. It may be desirable to have a core with a permeability of greater than 1. Moreover, because the distributed gap reduces eddy currents, there are fewer flux distortions. This relatively greater
isotropic structure provides for a more uniformly distributed flux and facilitates more complex and sophisticated core structures.
The ferromagnetic powder used to make the core may be made of particles that are less than 0.05 inch in diameter. Although it should be appreciated that the particles may be of any size in the contemplated embodiments, it should be appreciated
that the specific particle dimension is related to the frequency at which the core is to operate. For example, if the core is to be pulsed at a higher frequency, it may be desirable to use particles with a smaller dimension. The ferromagnetic particles
may vary in size and may not be spherical but rather irregular in shape. In any event, it should be appreciated that specific particle size may be selected to reduce losses resulting from eddy currents and hysteresis losses within individual particles.
Also, although the invention is not limited to any particular formation, it should be appreciated that individual ferromagnetic particles may be formulated from iron, iron alloys and amalgams of other conductive or partially conductive materials. Also, the material composition of the particles may include non-ferrous metals such as copper, brass, aluminum and alloying elements such as carbon, silicon, nickel and chromium formulated to create the desired crystal structure and desired magnetic
characteristics. Saturation, permeability and B-H curve characteristics vary depend on this selected formulation. In addition, the ferromagnetic particles may be coated with a non-conductive resin to, among other things, prevent oxidation while being
stored before the coated particles are formed into the desired structure in the core manufacturing process.
The contemplated embodiments include a method for manufacturing a magnetic core device, for example a powdered ferromagnetic core device. The method includes selecting certain powdered ferromagnetic materials. The materials are then mixed and
compressed to form the core. The powder may be pressed into a mold having the final form of the core. Alternatively, blocks of compressed material can be manufactured and subsequently machined to the desired geometry. Also, separate molded or machined
component pieces may be mechanically assembled into the final core geometry using cement, heating or bonding by other mechanical means. The ferromagnetic powder core may be produced by any of several processes. For example, stream of molten iron may be
atomized by a high pressure water jet.
The ferromagnetic particles may be coated with any appropriate substance. For example, the ferromagnetic particles may be coated with an insulative substance, like alkali metal silicate, for example. The insulative substance provides insulation
between each of the particles in the core, and thus creates the distributed gap core. In one embodiment, an aqueous alkali metal silicate solution is used containing up to 39% by weight solids of K.sub.2O and SiO.sub.2, and up to 54% by weight solids of
Na.sub.2O and SiO.sub.2. A wetting agent or surfactant, like alkyl phenoxyl polyethoxy ethanol for example, may be added to facilitate uniform coating of the particles.
The appropriate substances are mixed and may be surface-dried at the same time. A thin coating of an adherent resin may be applied to the ferromagnetic particles. Such resins may include polyimides, fluorocarbons and acrylics. The resin
permits the particles to remain flexible and thus capable of withstanding high temperatures without decomposing into conducting residues.
To form the core, the powder is compressed. The compression may be approximately in the range of 25 to 100 tons per square inch. A form may be used to create the desired shape. The pressed components may be annealed, for example, at 500 to 600
degrees Celsius to relieve the stresses and reduce the hysteresis losses.
If ferromagnetic powder is to be used for the magnetic core in such an application, the particles may be insulated from one another, for example, with between 1% to 3% spacing between particles. Although this is just one example. When raw
ferromagnetic powder is compressed up to 100 tons per square inch and not sintered, the density remains 1% or 2% below the true density of solid iron, because of residual crevices or interstices which remain empty or are filled with lower density resin.
As a result, the ferromagnetic powder may be compressed to about 90% of theoretical density or better in order to have a distributed insulation-containing air gap less than 3% in each of the three orthogonal directions, one of which is that of the flux
path. In any of the embodiments, the magnetic core may be a composition that allows the core to saturate at 0.5 Tesla or greater, for example.
During the manufacturing process, the individual ferromagnetic particles in the powder may be mixed with a binding material, for example phenolic or epoxy. The ferromagnetic powder may then be pressed into its final shape. Next, a baking or
heating process may be implemented to cure the core material. After the core has been cured, the ferromagnetic particles may be separated by air or insulative binding material which effectively results in a distributed gap. As a result, the gap is
distributed throughout the core.
The novel device and techniques may be used for many purposes including the treatment of patients with medical conditions. This applicability will be discussed in the context of TMS in order to provide greater understanding. However, it should
be appreciated that techniques have applicability beyond TMS also are contemplated by the invention.
In just one embodiment, a method of treating a patient by creating a magnetic field using a magnetic device having a non-linear core is contemplated. As will be discussed with reference to FIGS. 1-13, the core may assume a number of different
and various shapes and sizes. The shapes and sizes may vary with the particular area of the patient's anatomy that needs treatment, as well as the external area of the patient on which the magnet may be placed. For example, in just one embodiment, the
core may have a U-shaped structure that facilitates placing the core in close proximity to a patient's head for the purpose of treating the brain with pulsed magnetic fields for the treatment of depression. This may be accomplished, for example, by
stimulating tissue (e.g., brain tissue), nerves and/or muscle, for example, from an area relatively proximate to the cutaneous surface and the area of treatment.
Also, the core used to treat the patient may be a gap distributed core and more specifically an ferromagnetic powder core. As discussed, the embodiments are not limited to any compositions, but contemplate any material composition that
effectively creates a distributed gap core structure. Also, the embodiments contemplate any type of core structures, including ferromagnetic, where the shape of the core structure has a non-arc shaped structure. For example, the embodiments contemplate
the use of a non-sintered core material. Also, other embodiments contemplate a non-linear shaped ferromagnetic powder core.
The magnetic field passing through the core may be applied to the patient for the purpose of treating or diagnosing the patient. The embodiments are not limited to a specific level or intensity of the magnetic field, but instead contemplate any
field strength, focus and duration necessary to treat or diagnose the desired patient.
A novel system may include a magnetic field generating device created using a powdered ferromagnetic core, a circuit in electrical communication with the magnetic core, and being drive by a power source in electrical communication with the
circuit.
A power source may be provided in order for the core to generate the requisite magnetic field. The power source may be in electrical communication with the windings wrapped around a portion of the core. The power source may be created to
provide a substantially constant power or substantially constant current source. For example, the power source may provide a substantially constant power or substantially constant current source to a capacitor, which then discharges to the core to
create the magnetic field.
The power source may operate on an alternating current input voltage in the range of 85 volts to 264 volts. In this way, the inventive device may operate using power typically available in residential and commercial settings.
Finally, the embodiments contemplate a method for treating depression. As part of the method a patient is selected who suffering from a depressive disorder. The patient's brain is then magnetically stimulated using a transcranial magnetic
stimulator with a magnetic core. The core may be a ferromagnetic core having a U-shaped structure and/or a distributed gap core structure having any core shape and structure.
It should be appreciated that the use of ferromagnetic powder core makes more feasible many possible core geometries. In fact, the distributed gap core (e.g., ferromagnetic powder core) manufacturing process, allows the core's geometry to have
an array of possibilities. The precise shape and size of the core's geometry may be made to vary depending upon various factors. For example, although not an exclusive list of considerations, the following may be considered in deciding upon the size
and geometry of the core: the use of the core, the available mounting area and volume, the allowable radiation, the limitations on windings, the operating temperature, and how the core will be mounted. Consequently, a core's geometrical shape can take
any form, including a cylinder, bobbin, toroid, a non-toroid or several other possible shapes.
In addition, it also should be appreciated that the ferromagnetic powder manufacturing process facilitates construction of the core as multiple components or pieces. Multi-piece ferromagnetic powder cores, each piece made of similar or different
magnetic material, may be used for extremely complex shapes or larger core constructions. These individual pieces, of different or similar permeabilities, may be brought together by gluing and/or any other attachment techniques well known to those
skilled in the art. This is facilitated, in part, due to the ease of manufacturing and core shaping provided by the powder core process.
In addition, the powder core manufacturing process also facilitates the use of other materials to shape the magnetic field provided by the core structure. For example, it may be desirable to deflect or redirect a certain portion of the created
magnetic field away from certain parts of the anatomy. For example, for brain stimulation, it may be desirable to protect the trigeminal nerve from being stimulated and causing discomfort to the patient. This may be accomplished using any number of
techniques.
One example technique locates a conductor on a treatment area relative to the protected area. The conductor may act to reduce stimulation of a cutaneous-proximate area on the patient. This may be accomplished by modifying an electric or
magnetic field created by the transcutaneous stimulation. Also, it may be accomplished via modification of the electric field through modification of the magnetic flux created by the transcutaneous stimulation.
FIGS. 1 through 13 provide various examples of core shapes and configurations that are facilitated by the contemplated embodiments. It should be appreciated, however, that FIGS. 1 through 13 are not provided in order to detail every possible
shape and configuration contemplated by the invention. Instead, the figures merely provide certain examples to aid in an understanding of just a few of the contemplated embodiments.
Generally, it may be noted that the magnetic cores shown in FIGS. 1 through 13 essentially comprise three sections. Although the cores may not have to be separately constructed in three of such sections, describing their shape as such
facilitates further discussion of the shape, and thus is not meant to be limiting in any way.
FIG. 1 will be used to discuss the features of the core. As shown in FIG. 1, a core 100 includes a first section 101, a second section 102 and a third section 103. In the context of FIG. 1 which is a squared off U-shape, second section 102
serves as a bridge connecting first section 101 and third section 103, which serve as the posts or poles for the U-shape. First section 101 is joined with second section 102 at a right angle. Similarly, third section 103 is joined with second section
102 at a right angle. It should be appreciated that these sections may be fabricated as one complete pressed part, or they could be individually pressed and later assembled to form the U-shape.
As shown in FIGS. 2 through 13, various other shapes and configurations that may be modifications or minor alterations are depicted in FIG. 1. For example, as shown in FIG. 2, either ends of the first, second and/or third sections may be angled
or chamfered. Such angles or chamfering may be accomplished using any such value, for example using an angle of 45 degrees. Such modifications to the shape of the pole face are used by those skilled in the art to redirect and optimize the spatial
distribution of the magnetic field for the intended application. Also, the angled sections may be arc-shaped as shown in FIG. 3.
The angles may be made to both the cornered ends of the core as shown in FIG. 2, or on just one of the cornered ends of the core as shown in FIG. 13. Similarly, the angles may be made at the opposite ends with respect to the cornered ends, as
shown in FIG. 5. Alternatively, the angles depicted in FIG. 5 may be arc-shaped or smoothed, as shown in FIGS. 4 and 6. Also, the first and third sections may be L-shaped as shown in FIG. 7 with a linear second section, or as shown in FIG. 8 with an
arc-shaped second section.
As shown in FIG. 9, the magnetic core may be arc-shaped core having a wire wound around any portion of its axis. Alternatively, as shown in FIGS. 10 and 11, the core may be a linear-shaped structure having perpendicular or chamfered ends with
respect to its main axis. In both cases, a wire may be wound around any portion of its axis. The wound wire may be a single strand and or multiple strands in parallel electrically. The wire may include a metal sheet of conductive material with or
without insulation, and or an extruded magnet wire with or without insulation. Also, as shown in FIG. 12, the core may have more than 2 poles with windings around one or more of the poles.
It should be appreciated that the construction, size and shape of the core may be made to be dependent upon how the windings will be installed on the core component. For example, certain embodiments contemplate windings that are wound directly
around and/or on the core. Also, other embodiments may include windings that are wound on a sleeve or bobbin that is slipped over a portion of the core, or are wound on a mandrel, potted and removed for subsequent assembly onto the core. It should be
appreciated that certain embodiments may include a combination of the these approaches. A channel may be cut into the face of the pole in order to allow windings or wire to be installed. For example, a shorted turn may be inserted into the channel and
connected together outside of the channel.
The wire used for the windings may be insulated to prevent closely wound, adjacent turns from shorting out. In the context of directly wound windings, the wire may be of such a gauge as to prevent the core from cutting through the insulation,
for example with sharp surfaces or edges. Therefore, to accommodate such directly wound cores, the core may have a smooth winding surface, or in some cases may provide a corner radius to accommodate the turns.
The bobbin may be a structure that includes a single bobbin or multiple bobbins. The bobbin may provide insulation properties with respect to the rest of the core, as well as providing operation and safety capabilities. The wire may be wound
around the pole faces of the core. Where wire is wound around two or more poles, the number of turns of the winding may be equal between both poles. Also, the wire may be wound around a central point of the core, instead of or in addition to being
wound around the pole faces of the core. Where wound around both, the number of turns of the winding around the pole faces may be a fraction of the number of turns around the central point of the core.
Again, it should be appreciated that fabrication of a core by pressing ferromagnetic powder into a mold allows a diverse range of core shapes and therefore more varied winding solutions. For example, in one embodiment of a distributed gap core a
bobbin may be more readily used to accurately prefabricate and position the winding on the core.
FIGS. 1B, 2B and 3B illustrate how one or more wires may be wound around at least a portion of the magnetic core. As shown in FIGS. 1B, 2B and 3B, the windings may be wound around the first and third sections of the core. Such a winding may be
a single winding wound around the first and third sections, or two or more individual windings each wound around the first and third sections. Alternatively, as shown in FIGS. 1A, 2A and 3A, the winding may be wound around the second section of the
core. Again, the core winding may be a single winding or multiple windings.
FIG. 14 is a flow diagram of a method for treating a patient. As shown in FIG. 14, in 1401 a magnetic field is created using a distributed gap core magnetic device. In 1402, the magnetic device is placed proximate to a cutaneous area on the
patient, for example, in proximity to the patient's head. In 1403, a portion of the patient's anatomy that is desired to be treated (e.g., brain) is stimulated. In 1404, the magnetic field is applied to the patient. In 1405, the patient is treated,
for example for depression, incontinence, and weight control, with the magnetic field. Other types of conditions also may be treated using these techniques. These may include, but are not limited to, treating the peripheral nervous system,
rehabilitating the patient's muscle.
It also should be appreciated that the described techniques further may be used to directly diagnose a patient's condition. Also, the techniques may be used to diagnose a response to drugs or other therapy and/or to quantify effectiveness of
such therapies. In just one of many possible examples, pharmaceuticals may have effects (i.e., direct or secondary) on the performance of the central nervous system. These effects may be observed by providing stimulation (e.g., TMS) and observing
evoked potentials, motor response, conduction velocities or other responses, just to name a few of the many contemplated observed effects. Changes in response may be used to quantify performance or to determine optimal dosing, for example.
In addition, many pathologies may be diagnosed using the described techniques an investigative tool to observe neurological response. Such pathologies include, but are not limited to, degenerative diseases, extent of traumatic injury,
progression of diseases, systemic deficiencies, and congenital anomalies (e.g., tinnitus). A partial list of such conditions is provided here for the purposes of further understanding. However, the scope of the described embodiments are not limited to
this list. These include assessment or measuring effect of pharmaceuticals, including anti-convulsives, Alzheimer's medications, anti-psychotics, pain medications, anti-anxiety, hypnotics (sedatives), analgesics (central), ADHD medications and,
anesthetics. Just a few of the contemplated diagnostic applications include compromised motor function, degenerative diseases (e.g., Alzheimer's, Parkinson's, Amyotrophic Lateral Sclerosis), multiple sclerosis, diabetic neuropathy, chronic demyelinating
neuropathy, acute demyelinating neuropathy, epilepsy, vitamin B12 deficiency (e.g., pernicious anemia), vitamin E deficiency, neurosarcoidosis, tinnitus, and stroke rehabilitation.
Other disorders may also be treated with the described techniques including treating a patient such as a human suffering from major depressive disorder, epilepsy, schizophrenia, Parkinson's disease, Tourette's syndrome, amyotrophic lateral
sclerosis (ALS), multiple sclerosis (MS), Alzheimer's disease, attention deficit/hyperactivity disorder, obesity, bipolar disorder/mania, anxiety disorders (panic disorder with and without agoraphobia, social phobia also known as social anxiety disorder,
acute stress disorder, generalized anxiety disorder), post-traumatic stress disorder (one of the anxiety disorders in DSM), obsessive compulsive disorder (one of the anxiety disorders in DSM), pain (migraine, trigeminal neuralgia) (also: chronic pain
disorders, including neuropathic pain, e.g., pain due to diabetic neuropathy, post-herpetic neuralgia, and idiopathic pain disorders, e.g., fibromyalgia, regional myofascial pain syndromes), rehabilitation following stroke (neuro plasticity induction),
tinnitus, stimulation of implanted neurons to facilitate integration, substance-related disorders (dependence and abuse and withdrawal diagnoses for alcohol, cocaine, amphetamine, caffeine, nicotine, cannabis), spinal cord injury &
regeneration/rehabilitation, head injury, sleep deprivation reversal, primary sleep disorders (primary insomnia, primary hypersomnia, circadian rhythm sleep disorder), cognitive enhancements, dementias, premenstrual dysphoric disorder (PMS), drug
delivery systems (changing the cell membrane permeability to a drug), induction of protein synthesis (induction of transcription and translation), stuttering, aphasia, dysphagia, essential tremor, or eating disorders (bulimia, anorexia, binge eating).
The method further may include determining so-called "motor threshold" of the patient. More specifically, the magnetic device may be moved over a particular area until some indication of positioning is provided. For example, in the context of
magnetic stimulation of the brain, the magnetic device may be moved over the patient's head until the patient's thumb moves or twitches indicating a motor threshold point. This motor threshold determination may be at a similar or different frequency,
for example, using a stimulation frequency rate of 1 Hz.
From this point, the magnetic device may be moved to a desired treatment location. For example, for TMS treatment of the brain, the magnetic device may located approximately 5 centimeters anteriorly from motor threshold point. During TMS
treatment, in some embodiments, the stimulator output may be set to approximately 110% of relaxed motor threshold with perhaps a repetition rate of approximately 10 Hz.
FIG. 15 is a block diagram of a system for treating a patient. As shown in FIG. 15, a system 1500 for treating a patient includes a magnetic field generating device 1501. Magnetic field generating device 1501 may have a distributed gap core
structure. Also, a circuit 1502 is in electrical communication with the magnetic field generating device.
The circuit may be act as a switch to pulse the magnetic field generating device in such a way to treat the desired condition. In this way, the magnetic field may be applied to the patient in cycles intermittently. The exact stimulation
frequency or frequency in which the magnet is pulsed may be varied depending upon the particular application (e.g., size of magnet and area of stimulation). For example, in just some embodiments, it may be desirable to stimulate for a five second
period, followed by rest for a five second period and then repeat stimulation continuously for another five seconds. While they are being stimulated, it is desirable to have the muscle groups continuously excited. This requirement dictates the
necessity of continuing to pulse the cores at a repetition rate of 15 Hz. Because of the large currents involved during any given firing of the core, it is necessary to make the cores as efficient as possible. It is desirable to focus the magnetic
field into the region targeted for stimulus to the exclusion of surrounding regions. The specially designed cores offered by this invention realize that focusability.
In addition, a power source 1503 may be in electrical communication with the circuit. The power source may provide direct current (dc) or alternating current (ac) power. Also, the power levels may be consistent with those available in
residential and commercial settings.
FIG. 16 is a flow diagram of a method for manufacturing a magnetic core for treating a patient. As shown in FIG. 16, in 1601, ferromagnetic particles are selected with an insulated coating. In 1601, the ferromagnetic particles are mixed and in
1602, the ferromagnetic particles are formed into a core structure. In 1604, a conductor (e.g., wire) is wound around the core structure. In 1605, a power source is connected to the core structure.
Although not shown for the purposes of brevity, it should be appreciated that similar winding configurations may be applied to any of the possible core shapes, illustrated in the figures or otherwise. The description herein with regard to the
shapes and winding configurations of the core have been provided to facilitate the discussion and understanding of the many possible shapes and configuration that are within the scope of the contemplated embodiments. Similarly, it should be appreciated
that these shapes and configurations are equally applicable to any type of magnetic core used for treating and/or diagnosing a patient, including but not limited to pressed powder, sintered, tape wound, and coil only or "air" core structures.
It is to be understood that the foregoing illustrative embodiments have been provided merely for the purpose of explanation and are in no way to be construed as limiting of the invention. Words used herein are words of description and
illustration, rather than words of limitation. In addition, the advantages and objectives described herein may not be realized by each and every embodiment practicing the present invention. Further, although the invention has been described herein with
reference to particular structure, materials and/or embodiments, the invention is not intended to be limited to the particulars disclosed herein. Rather, the invention extends to all functionally equivalent structures, methods and uses, such as are
within the scope of the appended claims.
For example, although a great deal of the discussion was based on the use of a pressed powder distributed gap core structure, it should be appreciated that the contemplated embodiments include the use of any core structure, including "air core,"
non-sintered, and other ferromagnetic core structures for example. Moreover, although certain core shapes and configurations have been described herein, it should be appreciated that the shapes are provided merely to provide an understanding of the many
core shapes contemplated by the embodiments.
In addition, although the disclosure addresses the treatment of patients, it should be appreciated that techniques described herein also contemplate patient diagnosis. In fact, where the disclosure refers to the treatment of patients for certain
conditions, the techniques equally apply to the monitoring and diagnosis of patients for the same or similar conditions.
Those skilled in the art, having the benefit of the teachings of this specification, may affect numerous modifications thereto and changes may be made without departing from the scope and spirit of the invention.
* * * * *